dc.contributor.author |
Erdil, Nevzat |
|
dc.contributor.author |
Eroğlu, Tamer |
|
dc.contributor.author |
Akça, Barış |
|
dc.contributor.author |
Dişli, Olcay Murat |
|
dc.contributor.author |
Yetkin, Özkan |
|
dc.contributor.author |
Çolak, Mehmet Cengiz |
|
dc.contributor.author |
Erdil, Feray Akgül |
|
dc.contributor.author |
Battaloğlu, Bektaş |
|
dc.date.accessioned |
2017-07-15T12:41:55Z |
|
dc.date.available |
2017-07-15T12:41:55Z |
|
dc.date.issued |
2016 |
|
dc.identifier.citation |
ERDİL, N., EROĞLU, T., AKÇA, B., DİŞLİ, O. M., YETKİN, Ö., ÇOLAK, M. C., … BATTALOĞLU, B. (2016). The effects of N acetylcysteine on pulmonary functions in patients undergoing on pump coronary artery surgery a double blind placebo controlled study. Eur Rev Med Pharmacol Sci, 0–0. |
tr_TR |
dc.identifier.uri |
http://www.europeanreview.org/wp/wp-content/uploads/180-187.pdf |
|
dc.identifier.uri |
http://hdl.handle.net/11616/7398 |
|
dc.description |
European Review for Medical and Pharmacological Sciences |
tr_TR |
dc.description.abstract |
Abstract. – OBJECTIVE: To investigate the effects
of N-acetylcysteine (NAC) on pulmonary
function tests and arterial blood gases in patients
undergoing on-pump coronary artery surgery.
PATIENTS AND METHODS: The effect of NAC
was assessed within the scope of a prospective,
single center, double-blind, placebo-controlled,
parallel group study. Eighty-two patients
undergoing coronary artery bypass grafting
were randomized into two groups to receive either
placebo (group 1, n = 40) or NAC (group 2,
n=42). Both the NAC group and the placebo-receiving
control group also included a COPD
subgroup consisting of patients with an
FEV1/FVC ratio of < 0.7 and an FEV1 value of 50-
80%. Pulmonary function tests were performed
preoperatively and on postoperative day 60.
RESULTS: Both groups were similar with respect
to age, gender, preoperative risk factors,
ejection fraction (EF), mean cross-clamp time,
ventilation time, intensive care unit (ICU) stay,
atrial fibrillation (AF) and hospital stay (p > 0.05).
Postoperative FVC and FEV1 values in group 1
and the postoperative FEV1, FEV1/FVC and FEF
25-75 values in group 2 were lower in comparison
to their preoperative values. However, in
both group 1 and 2, the decreases observed in
these parameters were not statistically significant
(p > 0.05). In the COPD subgroup of group
1, a postoperative decrease was observed in the
FEV1 and FEF25-75 values, with the FEV1 decreasing
by 4.55%, and the FEF25-75 decreasing
by 4.2% (p < 0.05). In the COPD subgroup of
group 2, no significant decrease was observed
in the pulmonary function test values (p > 0.05). |
tr_TR |
dc.language.iso |
eng |
tr_TR |
dc.publisher |
Eur rev med pharmacol sci |
tr_TR |
dc.rights |
info:eu-repo/semantics/openAccess |
tr_TR |
dc.subject |
N-Acetylcysteine |
tr_TR |
dc.subject |
Pulmonary function test |
tr_TR |
dc.subject |
Bypass surgery |
tr_TR |
dc.subject |
Coronary artery |
tr_TR |
dc.title |
The effects of N acetylcysteine on pulmonary functions in patients undergoing on pump coronary artery surgery a double blind placebo controlled study |
tr_TR |
dc.type |
article |
tr_TR |
dc.relation.ispartof |
Eur rev med pharmacol sci |
tr_TR |
dc.department |
İnönü Üniversitesi |
tr_TR |
dc.authorid |
8752 |
tr_TR |
dc.authorid |
239816 |
tr_TR |
dc.authorid |
239816 |
tr_TR |
dc.authorid |
110112 |
tr_TR |
dc.authorid |
9608 |
tr_TR |
dc.identifier.volume |
0 |
tr_TR |
dc.identifier.issue |
0 |
tr_TR |
dc.identifier.startpage |
0 |
tr_TR |
dc.identifier.endpage |
0 |
tr_TR |